Publicaciones en colaboración con investigadores/as de Universidad de Navarra (14)

2022

  1. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study

    BMC Cancer, Vol. 22, Núm. 1

2020

  1. A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428

  2. Holistic approach of the care of the infant with hypoxic-ischaemic encephalopathy in Spain

    Anales de Pediatria, Vol. 92, Núm. 5, pp. 286-296

  3. Molecular features of metaplastic breast carcinoma: An infrequent subtype of triple negative breast carcinoma

    Cancers, Vol. 12, Núm. 7, pp. 1-13

2018

  1. Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?

    Breast, Vol. 41, pp. 133-135

2016

  1. Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile

    Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428

2015

  1. Prevalence of the different lumbar back pain etiologies in Spain: results from a large observational study in 306 centers (the SMILE study)

    European Orthopaedics and Traumatology, Vol. 6, Núm. 4, pp. 451-459

2013

  1. Neuralgiadel trigémino: Radiofrecuencia ganglio de Gasser

    Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 2, pp. 89-100

2005

  1. Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 61, Núm. 5, pp. 1378-1384

  2. Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?

    World Journal of Gastroenterology

2002

  1. Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer: A feasibility pilot study

    Oncology, Vol. 63, Núm. 3, pp. 254-265

  2. Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: A phase II study

    Clinical Colorectal Cancer, Vol. 2, Núm. 2, pp. 104-110

2001

  1. Fixed higher dose schedule of suramin plus hydrocortisone in patients with hormone refractory prostate carcinoma: A multicenter phase II study

    Cancer, Vol. 92, Núm. 9, pp. 2435-2443

2000

  1. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma: A phase II study

    Cancer, Vol. 89, Núm. 12, pp. 2622-2629